Skip to content

Clinical trials

Phase 1 Lung Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 1 Country / region: Canada Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20033
20041
20052
20062
20073
20082
20091
20101
20121
20141
20153
20164
20173
20181
20191
20203
20212
20223
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed25
Terminated7
Recruiting5
Active, not recruiting4
Unknown status2
Suspended1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
University Health Network, Toronto6
Centre hospitalier de l'Université de Montréal (CHUM)3
NCIC Clinical Trials Group3
Blueprint Medicines Corporation2
British Columbia Cancer Agency2
National Cancer Institute (NCI)2
St. Joseph's Healthcare Hamilton2
AHS Cancer Control Alberta1
Amgen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms45
Carcinoma, Non-Small-Cell Lung20
Colorectal Neoplasms9
Breast Neoplasms7
Neoplasms7
Ovarian Neoplasms6
Small Cell Lung Carcinoma6
Carcinoma, Renal Cell4
Colonic Neoplasms4
Melanoma4

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.